Enemem,
A miscalculation of that caliber would be grounds for a lynching, no pun intended.
Gershfinance,
A leverage financing from shareholders would be great in a fantasy world but in todays climate, I don't see anyone pulling leveraged cash to support an unstable bio-tech that can't seem to get out of its own way. If I had access to 500k in an available equity draw or such I think I would be putting it in valued but depressed securities that offer far more generous upside and stable returns than that of Cor options based on the hope of Cor's fab four finally getting a deal done. Urgency and value don't seem to go well together. The value of this deal is shrinking daily. Maybe Stoll can do a share purchase with options...he probably has a few mill of Cor bucks sitting in a 401k or fund of some kind. If not, there's always the sp friendly R&R funding family, why not give them an opportunity to steal more shares and options while we once again sit idle watching our value dimish. A buyout or selling of the company IP seems like the best option for shareholders at this point, unless of course you like several more years of wait and see type mentality.